Navigation Links
Amgen Award For Science Teaching Excellence Honors Outstanding Teachers
Date:6/19/2013

THOUSAND OAKS, Calif., June 19, 2013 /PRNewswire/ -- Amgen is pleased to announce the nine science teachers in the United States, Canada and Puerto Rico who are this year's recipients of the Amgen Award for Science Teaching Excellence (AASTE). Now in its 21st year, the award recognizes extraordinary teachers at the kindergarten through 12th grade level who have an outstanding ability to inspire students and produce results in science education.

With a long-standing commitment to science education, Amgen established the teacher awards program to promote and encourage science teaching excellence in public and private schools. Since the program's inception in 1992, Amgen has awarded more than $3 million in cash awards and grants to educators in communities where Amgen operates who have made exceptional science-teaching contributions.

"At Amgen, we are keenly aware of the importance of inspiring and preparing the next generation of scientists," said Joseph P. Miletich, M.D., Ph.D., senior vice president of Research and Development at Amgen. "We applaud each of the award recipients for their dedication to delivering quality science education to tomorrow's innovators."

In 2013, the Award for Science Teaching Excellence winners were honored at surprise presentations at their schools. The 2013 award recipients are:

Mary Murphy, The Urban School of San Francisco, San Francisco, Calif.
Laura Todis, Sierra High School, Fillmore, Calif.
Mark Paricio, Smoky Hill High School, Aurora, Colo.
Susan Buehner, Brandeis Elementary School, Louisville, Ky.
Rebekah Ravgiala, Tyngsborough High School, Tyngsborough, Mass.
Luz Burgos, Colegio Radians, Cayey, Puerto Rico
David Upegui, Central Falls High School, Central Falls, R.I.
Amanda Rainwater, Bothell High School, Bothell, Wash.
Glyn Davies, Henry Anderson Elementary School, Richmond, British Columbia, Canada

Winners are selected based on a variety of criteria including, among others, a teacher's ability to effectively engage students while deepening their scientific understanding, the plan for the use of grant money to improve science education resources in their schools, and a letter of recommendation.

The nine selected winners receive the following benefits:

  • An unrestricted cash award of $5,000 USD or $5,000 CAD; and
  • A restricted $5,000 USD or $5,000 CAD cash grant to the recipient's school for the expansion or enhancement of a school science program, science resources, or the professional development of the school's science teachers.

Amgen partnered with Education Development Center (EDC) to select the 2013 AASTE recipients. EDC is a global non-profit organization that designs, delivers and evaluates innovative programs to address some of the world's most urgent challenges in education, health, and economic opportunity.

The AASTE awards provided to teachers in the United States were funded by the Amgen Foundation and the award in Canada was funded by Amgen.

For more information about this year's winners and the program, please visit http://www.amgen.com/citizenship/aaste.html.

About the Amgen Foundation
The Amgen Foundation (www.amgen.com/citizenship/overview.html) seeks to advance science education; improve patient access to quality care; and strengthen the communities where Amgen staff members live and work. To date, the Foundation has donated over $200 million in grants to nonprofit organizations throughout the United States, Puerto Rico and Europe that impact society in inspiring and innovative ways, and those that provide disaster relief efforts both domestically and internationally. The Amgen Foundation can be followed on Twitter at www.twitter.com/AmgenFoundation.

About Amgen
Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe, effective medicines from lab to manufacturing plant to patient. Amgen therapeutics have changed the practice of medicine, helping people around the world in the fight against serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. For more information, visit www.amgen.com and follow us on www.twitter.com/amgen.

CONTACT: Amgen, Thousand Oaks
Kristen Davis, 805-447-3008 (media)

(Logo: http://photos.prnewswire.com/prnh/20081015/AMGENLOGO)


'/>"/>
SOURCE Amgen
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Amgen Announces Top-Line Results Of Phase 3 Trebananib (AMG 386) TRINOVA-1 Trial In Recurrent Ovarian Cancer
2. Amgen Presents Positive Results From Talimogene Laherparepvec Phase 3 Study In Patients With Metastatic Melanoma
3. Amgen To Webcast Investor Meeting At Upcoming American Society Of Clinical Oncology Annual Meeting
4. Amgen And Astellas Announce Japan Alliance
5. Amgen to Present at the Deutsche Bank 38th Annual Healthcare Conference
6. Amgen To Present At The UBS Global Life Sciences Conference
7. The Zacks Analyst Blog Highlights: Genomic Health, Sanofi, Regeneron Pharmaceuticals, Amgen and Isis Pharmaceuticals
8. Amgen Highlights Data To Be Presented At American Society of Clinical Oncology Annual Meeting
9. Amgen, Hospira and Sandoz Named Among Top Pharmaceutical Companies with Greatest Biosimilar Drug Potential in United States
10. Amgen And Zhejiang Beta Pharma Announce Planned Joint Venture In China
11. Amgens First Quarter 2013 Revenues Increased 5 Percent To $4.2 Billion And Adjusted Earnings Per Share (EPS) Increased 22 Percent To $1.96
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)...  Arkis BioSciences, a leading innovator in the ... cerebrospinal fluid treatments, today announced it has secured ... led by Innova Memphis, followed by Angel Capital ... Arkis, new financing will accelerate the commercialization of ... of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... , June 23, 2016 Any dentist who has ... of the current process. Many of them do not even ... technical difficulties and high laboratory costs involved. And those who ... it at such a high cost that the majority of ... Dr. Parsa Zadeh , founder of Dental Evolutions ...
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: RO, ... clearance for its Elecsys BRAHMS PCT (procalcitonin) assay as ... or septic shock. With this clearance, Roche is the ... fully integrated solution for sepsis risk assessment and management. ... bacterial infection and PCT levels in blood can aid ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... ... issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the ... several important health care topics including advance care planning, healthcare costs and patient ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX users ... - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 ... Pro X . Simply select a ProHand generator and drag it above media or ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin ... injury. Recently, he has implemented orthobiologic procedures as a method for treating his ... of the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic ...
(Date:6/24/2016)... Los Angeles, CA (PRWEB) , ... June 24, 2016 , ... ... plastic surgery procedures that most people are unfamiliar with. The article goes on to ... known procedures, but also many of these less common operations such as calf and ...
(Date:6/24/2016)... ... ... a crisis. Her son James, eight, was out of control. Prone to extreme mood shifts ... upset him, he couldn’t control his emotions,” remembers Marcy. “If there was a knife ... and say he was going to kill them. If we were driving on the ...
Breaking Medicine News(10 mins):